Armata Pharmaceuticals (ARMP) vs Blue Water Acquisition III - Unit. (BLUWU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Armata Pharmaceuticals (ARMP) has outperformed Blue Water Acquisition III - Unit. (BLUWU) over the past year, gaining 19.9% versus a gain of 4.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARMP | BLUWU |
|---|---|---|
| Share price | $3.84 | $10.50 |
| Market cap | $142.78M | — |
| 1-day change | -0.52% | 0.00% |
| YTD return | -38.54% | -0.47% |
| 1-year return | +19.88% | +4.69% |
| 5-year return | +11.88% | — |
| EPS (TTM) | $-5.29 | — |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.34 | $12.85 |
| 52-week low | $3.14 | $10.03 |
| Distance from 52-week high | -76.50% | -18.29% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +355.73% | — |
| Average volume | 208.13K | 48 |
| Shares outstanding | 37.18M | — |
| Employees | 61 | — |
| Sector | Health Care | Financial Services |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Shell Companies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ARMP has outperformed BLUWU by 15.2 percentage points over the past year.
- The two companies sit in different sectors: Armata Pharmaceuticals in Health Care and Blue Water Acquisition III - Unit. in Financial Services.
About Armata Pharmaceuticals
ARMP stock →Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 61 employees
About Blue Water Acquisition III - Unit.
BLUWU stock →Blue Water Acquisition Corp. III does not have significant operations.
Financial Services · Shell Companies
ARMP vs BLUWU FAQ
Which stock has performed better over the past year, ARMP or BLUWU?
ARMP returned +19.88% over the past 12 months, compared with +4.69% for BLUWU (price return, excluding dividends). Past performance does not predict future results.
Are Armata Pharmaceuticals and Blue Water Acquisition III - Unit. in the same industry?
No. Armata Pharmaceuticals is in the Health Care sector, while Blue Water Acquisition III - Unit. is in Financial Services.